mazindol , when given to obese subjects in conjunction with a hypocaloric diet , was associated with progressive weight loss and reduction in the fasting levels of blood glucose , plasma insulin , serum triglyceride , and serum cholesterol .
C0024977
mazindol
C0028754
obese